OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
January 17, 2022
Protective external packaging ensures COVID-19 vaccines arrive safely.
January 11, 2022
The agreement expands Pfizer’s access to LNP formulation technology for mRNA vaccines and therapeutics.
January 07, 2022
Intravacc is partnering with Leiden University Medical Center for the development and evaluation of a new intranasal coronavirus vaccine candidate in a clinical Phase I/II study.
January 03, 2022
Workforce training is crucial for biopharmaceutical manufacturing.
December 10, 2021
Guide addresses challenges of applying GMPs to autologous cell therapy manufacturing.
December 03, 2021
Fujifilm’s center adds local support in Suzhou, China for cell culture media optimization.
Increased patient-centricity and alternative dosage forms require careful consideration when selecting the best taste-masking approach.
December 01, 2021
CordenPharma will build a clinical trial development facility for manufacture of oral solid dosage drug products at its Plankstadt facility near Heidelberg, Germany.
November 29, 2021
Samsung Biologics, GreenLight Biosciences, and Environmental Impact Acquisition Corp. have partnered to advance GreenLight’s mRNA COVID-19 vaccine candidate.
The companies are testing their existing vaccines against the new variant of concern and are pursuing variant-specific versions.
